Johnson & Johnson (JNJ) – One of the 12 High Dividend Stocks Picked by Billionaire Ray Dalio

Johnson & Johnson (NYSE:JNJ) is included among the 12 High Dividend Stocks Picked by Billionaire Ray Dalio.

On April 15, Bank of America raised its price recommendation on Johnson & Johnson (NYSE:JNJ) to $254 from $253. It kept a Neutral rating on the shares. The firm described the quarter as “an okay 1Q print” that “offered nothing thesis changing.”

During the Q1 2026 earnings call, CFO Joseph Wolk said the company raised its operational sales outlook to a range of 5.9% to 6.9%, with a midpoint of $100.2 billion. He added that reported sales are now expected to grow between 6.5% and 7.5%, implying a midpoint of $100.8 billion. He also said earnings guidance was lifted by $0.02, bringing the expected range to $11.30 to $11.50.

At the same time, the company maintained its view that the adjusted pretax operating margin will improve by at least 50 basis points in 2026. He noted that a larger share of investments will be weighted toward the first half of the year. Compared with the initial 2026 outlook shared in Q4, he pointed out a shift in tone. Management moved from saying they “anticipated” growth to indicating they are actively increasing both sales growth and adjusted EPS guidance ranges.

Johnson & Johnson (NYSE:JNJ) is a global healthcare company that operates across the healthcare sector through its Innovative Medicine and MedTech segments.

READ NEXT: Top 10 Reddit Stocks That Will Skyrocket and 10 Fastest Growing Dividend Stocks to Buy Now

Disclosure: None. Follow Insider Monkey on Google News.